-
Sector Analysis
NewUnited Kingdom (UK) Mother’s Day Market Analysis, Trends, Consumer Attitudes and Buying Dynamics, 2024 Update
United Kingdom (UK) Mother’s Day Market Report Overview The report suggests that over a third of male consumers agreed they spend more on taking their mother for a meal than buying a tangible gift. Indeed, if retailers cannot make gifting selections more appealing, consumers will turn to leisure over retail to mark the occasion. Therefore, retailers must promote experience gifts, which grew in popularity this year to compete with leisure options, such as dining out. The UK Mother’s Day market...
-
Product Insights
Biliary Tumor – Drugs In Development, 2023
Global Markets Direct’s, ‘Biliary Tumor - Drugs In Development, 2023’, provides an overview of the Biliary Tumor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Biliary Tumor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Sector Analysis
NewUnited Kingdom (UK) Valentine’s Day – Analyzing Market, Trends, Consumer Attitudes and Major Players, 2024 Update
United Kingdom (UK) Valentine’s Day Market Report Overview The proportion of UK consumers shopping for Valentine’s Day has declined in 2024. Muted interest in spending on retail has significantly contributed to the decline in Valentine’s Day shopping. The other key factor influencing the decline is the diminishing significance of Valentine’s Day. As consumers continue to feel the impact of inflation, over 50% of consumers agree that the cost-of-living crisis has reduced spending for the occasion. They are more likely to...
-
Product Insights
Natural Killer Cell Lymphomas – Drugs In Development, 2023
Global Markets Direct’s, ‘Natural Killer Cell Lymphomas - Drugs In Development, 2023’, provides an overview of the Natural Killer Cell Lymphomas pipeline landscape. The report provides comprehensive information on the therapeutics under development for Natural Killer Cell Lymphomas, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Sector Analysis
United Kingdom (UK) Retail Occasions Market by Sector, Size, Share and Growth Analysis to 2023
Reasons to buy the ‘UK Retail Occasions’ market report: The report offers a comprehensive overview of the market size for key occasions from 2018-2023. These key occasions are Valentine's Day, Mother's Day, Easter, Father's Day, summer holidays, back to school, Halloween, Black Friday, and Christmas. The report analyses the market growth and the market shares of the top five retailers for each key occasion overall, and for core categories. How is our ‘UK Retail Occasions’ report unique from other reports...
-
Product Insights
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) – Drugs In Development, 2023
Global Markets Direct’s, ‘Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Drugs In Development, 2023’, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Peripheral T-Cell Lymphomas (PTCL) – Drugs In Development, 2023
Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Drugs In Development, 2023’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Peripheral T-Cell Lymphomas (PTCL), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...